Last reviewed: June 6, 2026

Last updated: June 6, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Glucagon-like peptide-1 (GLP-1) is produced deep within your intestines by specialized endocrine cells called L-cells, which line the lower small intestine and colon. When you eat, especially foods containing glucose or amino acids, these L-cells immediately release GLP-1 into the bloodstream. Understanding where GLP-1 originates helps explain why GLP-1 therapies like semaglutide have become so effective for weight loss and metabolic control.

The Intestinal Source of GLP-1 Production

GLP-1 originates from L-cells, a type of enteroendocrine cell scattered throughout your intestinal lining. These cells make up less than 1% of your gut epithelium but play an outsized role in metabolic regulation. L-cells are most concentrated in the terminal ileum and colon, the final sections of your small intestine and large intestine. When nutrients pass through these regions, L-cells sense them through chemoreceptors and immediately secrete GLP-1 into the portal blood circulation.

The production of GLP-1 is not constant—it responds directly to what you eat and when you eat. Carbohydrates, proteins, and especially glucose are the primary triggers for L-cell activation. Once released, GLP-1 travels through your bloodstream to your brain, pancreas, and stomach, where it exerts its appetite-suppressing and glucose-regulating effects. This nutrient-sensing system evolved to help your body process meals efficiently and maintain stable blood sugar.

How GLP-1 Controls Hunger and Blood Sugar

After GLP-1 is released from intestinal L-cells, it acts on multiple sites in your body to reduce hunger and slow gastric emptying. In the brain, GLP-1 crosses the blood-brain barrier and binds to GLP-1 receptors in the hypothalamus, the region controlling appetite and satiety. This signaling tells your brain that you are full, even when you've consumed fewer calories than before. Meanwhile, GLP-1 slows the rate at which your stomach empties food into the small intestine, prolonging the sensation of fullness.

GLP-1 also stimulates the pancreas to release insulin in response to elevated blood glucose, helping your body process sugar more efficiently. This dual action—appetite suppression plus improved insulin secretion—makes GLP-1 a powerful regulator of both body weight and metabolic health. People with obesity or type 2 diabetes often have blunted GLP-1 responses, meaning their L-cells produce less of this hormone or their bodies don't respond as effectively to it.

Why GLP-1 Therapy Mimics Your Body's Natural System

GLP-1 medications like compounded semaglutide injection replicate the signal your intestinal L-cells send when you consume food, but in a sustained and amplified way. Rather than producing GLP-1 only after meals, semaglutide maintains steady GLP-1 levels throughout the day and week. This continuous activation of GLP-1 receptors in the brain and stomach creates a prolonged sense of satiety, allowing you to eat less without feeling deprived. The medication essentially extends the appetite-suppressing effect your body naturally produces, but in a controlled, measurable dose.

PlexusDx offers compounded semaglutide injection starting at $149 per month through licensed 503A compounding pharmacies in all 50 states. Because the dose may increase over time as your body adjusts, PlexusDx pricing remains flat—your dose may go up, but your price won't. This approach aligns treatment with your body's own GLP-1 system, working with your biology rather than against it.

Genetic Factors Affecting Your GLP-1 Response

Not everyone's L-cells respond the same way to food, and not everyone responds identically to GLP-1 therapy. Genetic variations in the GLP1R gene (the receptor that responds to GLP-1) and related metabolic pathways influence how much GLP-1 your body produces and how effectively your tissues respond to it. The GLP1R rs6923761 variant, for example, can affect the number and sensitivity of GLP-1 receptors in your brain and gut. Similarly, variants in the FTO and MC4R genes influence appetite regulation and energy metabolism independent of GLP-1 alone.

PlexusDx Precision Peptide Genetic Test analyzes 14 metabolic pathways across 49 peptides and 150+ genetic insights to reveal your individual predisposition to GLP-1 responsiveness. This test costs $99 as an add-on after your first month of treatment and helps personalize your GLP-1 therapy strategy. Understanding your genetic profile enables PlexusDx to recommend whether semaglutide injection, oral semaglutide, tirzepatide, or a dual-compound approach like GLP-Squared may align best with your biology.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Exactly where in the intestine are GLP-1-producing cells located?

GLP-1 is produced by L-cells scattered throughout your intestinal lining, with the highest concentration in the terminal ileum (last part of small intestine) and colon. These specialized endocrine cells make up less than 1% of your gut epithelium but trigger GLP-1 release whenever you eat nutrients like glucose or amino acids. PlexusDx therapy works by supplementing the GLP-1 signal these L-cells naturally produce.

What exactly triggers L-cells to release GLP-1?

L-cells release GLP-1 in response to nutrient intake, particularly carbohydrates, proteins, and fats passing through the intestine. The cells sense these nutrients through chemoreceptors on their surface and immediately secrete GLP-1 into the bloodstream. This response typically occurs within minutes of eating and is one of your body's primary mechanisms for controlling appetite and blood sugar after meals.

How does PlexusDx semaglutide injection mimic my body's natural GLP-1?

PlexusDx compounded semaglutide injection replaces the GLP-1 signal your intestinal L-cells produce, but maintains it consistently throughout the day rather than only after meals. Starting at $149 per month, semaglutide activates the same GLP-1 receptors in your brain and stomach that your body's natural GLP-1 would, creating sustained appetite suppression and improved metabolic control. PlexusDx serves all 50 states with no insurance required and HSA/FSA eligibility.

Can I increase my GLP-1 dose if the starting dose doesn't work?

Yes, many patients benefit from dose adjustments over their first several months of treatment as their body adapts and needs increase. PlexusDx pricing remains flat regardless of dose increases—your dose may go up, but your price won't. This pricing structure ensures that optimizing your therapy for maximum results never means paying more each month.

How does the PlexusDx Precision Peptide Genetic Test help me understand my GLP-1 response?

The Precision Peptide Genetic Test ($99 add-on after month one) analyzes your GLP1R gene variant, FTO rs9939609, MC4R rs17782313, and GIPR rs1800437 polymorphisms across 14 metabolic pathways. These genetic insights reveal whether you're likely a strong responder to GLP-1 therapy, whether dual-agent compounds may work better, and which peptide-based approaches align with your biology. This personalization helps PlexusDx recommend semaglutide, tirzepatide, or GLP-Squared based on your unique genetic predispositions.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves